Suraksha Diagnostic informs about press release

07 Mar 2025 Evaluate
In continuation to intimation letter dated 08 February 2025 and pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Suraksha Diagnostic has  enclosed the press release in relation to the appointment of the Ravindra K S as the Chief Financial Officer with effect from 01 March 2025, who will also act as a Group Chief Financial Officer of the Company. 

The above information is a part of company’s filings submitted to BSE.

Suraksha Diagnostic Share Price

308.65 -4.65 (-1.48%)
28-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7043.80
Max Healthcare Inst 1099.50
Narayana Hrudayalay 1793.05
Aster DM Healthcare 513.10
Global Health 1201.50
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...